NCT01770665View on ClinicalTrials.gov

Validation of the MiCK Assay

TerminatedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

September 30, 2016

Conditions
Mesothelioma, Small Cell Lung Cancer, NSCLC
Trial Locations (1)

55901

Mayo Validation Support Services 3050 Superior Drive NW, Rochester

Sponsors
All Listed Sponsors
lead

Pierian Biosciences

INDUSTRY